Richard Pulik
CIK 1885841 · CFO · last filed 2026-11-12
Richard Pulik is a CFO who has filed 69 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for ROIV, was dated Nov 13, 2026. Across all open-market trades the lifetime net is −$21.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.7M across reported positions. 67 SEC filings were submitted jointly with Roivant Sciences Ltd. 12 Form 144 notices of planned sales are also on file; the latest, for ROIV on Nov 13, 2026, lists the filer as an officer. 11 sales listed on those notices, worth $248.1K in all, have no matching Form 4.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ROIV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
7TH FLOOR
LONDON SW1H 0DB
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | CFO | 222,046 | $39.17 | $8.70M | -$21.60M | 47 | 2026-11-12 |
| Roivant Sciences Ltd. (ROIVW) Delisted | CFO | 282,195 | $2.75 | $776.0K | -$15.4K | 10 | 2023-09-01 |
Recent Filings
69 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-11-13 | ROIV | Notice (144/A) Officer · Planned Nov 10, 2026 Sold: Form 4 filed Nov 12, 2026 |
−125,000 | -$5.15M | EDGAR |
| 2026-11-13 | ROIV | Notice (144/A) Officer · Planned Nov 11, 2026 Sold: Form 4 filed Nov 12, 2026 |
−175,000 | -$7.32M | EDGAR |
| 2026-11-12 | ROIV | Mixed | −47,635 | -$11.50M | EDGAR |
| 2026-09-22 | ROIV | Tax (F) | −2,129 | -$84.7K | EDGAR |
| 2026-08-24 | ROIV | Tax (F) | −5,749 | -$211.8K | EDGAR |
| 2026-06-23 | ROIV | Tax (F) | −2,129 | -$66.9K | EDGAR |
| 2026-05-22 | ROIV | Tax (F) | −18,962 | -$614.6K | EDGAR |
| 2026-04-22 | ROIV | Grant (A) | +60,644 | $0 | EDGAR |
| 2026-03-24 | ROIV | Tax (F) | −1,546 | -$42.8K | EDGAR |
| 2026-02-24 | ROIV | Tax (F) | −1,000 | -$27.1K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
11 sales · $248.1K| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2023-10-30 | ROIV | 2,360 | $19.8K | $8.39 | 2023-11-29 |
| 2023-09-29 | ROIV | 2,483 | $29.4K | $11.86 | 2023-10-30 |
| 2023-08-29 | ROIV | 2,368 | $26.5K | $11.19 | 2023-09-29 |
| 2023-08-01 | ROIV | 2,306 | $27.3K | $11.86 | 2023-08-29 |
| 2023-06-29 | ROIV | 1,667 | $16.9K | $10.11 | 2023-07-31 |
| 2023-05-31 | ROIV | 1,711 | $15.5K | $9.08 | 2023-06-29 |
| 2023-05-01 | ROIV | 1,667 | $14.4K | $8.61 | 2023-05-30 |
| 2023-03-29 | ROIV | 1,639 | $12.0K | $7.35 | 2023-05-30 |
| 2023-03-29 | ROIV | 4,584 | $33.7K | $7.35 | 2023-05-01 |
| 2023-03-01 | ROIV | 1,912 | $15.4K | $8.08 | 2023-05-30 |
| 2023-03-01 | ROIV | 4,583 | $37.1K | $8.09 | 2023-05-01 |